Introduction Pharmacotherapy plays a critical role in the delivery of high-quality palliative
care, but the intersection of palliative care and deprescribing has received little attention …

Objectives Patients with life-limiting illnesses are prone to unnecessary polypharmacy.
Deprescribing tools may contribute to minimizing negative outcomes. Thus, the aims of the …

Background Even though antithrombotic therapy has probably little or even negative effects
on the well-being of people with cancer during their last year of life, deprescribing …

Background: Although prescribing and deprescribing practices in older people have been
the subject of much research generally, there are limited data in older people at the end of …

Background: The benefits and harms of anticoagulants for people near the end of life are not
well understood, nor is it known what proportion of patients discontinue these medications …

Objective To provide an integrated approach for deprescribing practice in oncology setting.
Data sources The data on deprescribing in oncology settings has been retrieved from the …

Dementia is one of the leading causes of death in the US. Approximately, 6 million elderly
people in the US had dementia in 2020. Advanced dementia is complicated by multiple …

Active cancer by itself but also chemotherapy is associated with an increased risk of
cardiovascular disease (CVD) and especially coronary artery disease (CAD) and atrial …

Objetivo los pacientes con enfermedades terminales son propensos a la polifarmacia
innecesaria. Las herramientas de desprescripción pueden contribuir a minimizar los …

Background: Even though antithrombotic therapy has probably little or even negative effects
on the well-being of people with cancer during their last year of life, deprescribing …